M Shaharabany

1.1k total citations
20 papers, 975 citations indexed

About

M Shaharabany is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, M Shaharabany has authored 20 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Virology and 8 papers in Infectious Diseases. Recurrent topics in M Shaharabany's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (8 papers) and Ion Transport and Channel Regulation (5 papers). M Shaharabany is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (8 papers) and Ion Transport and Channel Regulation (5 papers). M Shaharabany collaborates with scholars based in Israel and United States. M Shaharabany's co-authors include Amnon Hizi, Rony Seger, Ronen Schweitzer, Ben‐Zion Shilo, R. Tal, Stephen H. Hughes, Shoshana Loya, Zvi Farfel, Haim Mayan and Meir Mouallem and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

M Shaharabany

20 papers receiving 958 citations

Peers

Countries citing papers authored by M Shaharabany

Since Specialization

Citations

This map shows the geographic impact of M Shaharabany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Shaharabany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Shaharabany more than expected).

Fields of papers citing papers by M Shaharabany

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Shaharabany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Shaharabany. The network helps show where M Shaharabany may publish in the future.

Co-authorship network of co-authors of M Shaharabany

This figure shows the co-authorship network connecting the top 25 collaborators of M Shaharabany. A scholar is included among the top collaborators of M Shaharabany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Shaharabany. M Shaharabany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	β-Galactosidase activity and H ₂ S production in an experimental oral biofilm 2009 ·Journal of Breath Research ·Nir Sterer, M Shaharabany, M Rosenberg	19
2	Distinct pathways for the involvement of WNK4 in the signaling of hypertonicity and EGF 2008 ·FEBS Journal ·M Shaharabany, Eliezer J. Holtzman, Haim Mayan, Koret Hirschberg, Rony Seger, Zvi Farfel	15
3	Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsα 2007 ·Clinical Endocrinology ·Meir Mouallem, M Shaharabany, Naomi Weintrob, Shlomit Shalitin, Nessia Nagelberg, Hagit Shapira, Zvi Zadik, Zvi Farfel	46
4	Increased urinary Na-Cl cotransporter protein in familial hyperkalaemia and hypertension 2007 ·Nephrology Dialysis Transplantation ·Haim Mayan, (unknown), M Shaharabany, Eliezer J. Holtzman, Zvi Farfel	35
5	Resolution of hypertension during pregnancy in familial hyperkalemia and hypertension with the WNK4 Q565E mutation 2005 ·American Journal of Obstetrics and Gynecology ·Haim Mayan, Meir Mouallem, M Shaharabany, Rachel Pauzner, Zvi Farfel	9
6	WNK4 regulates Na⁺ transport in airways 2005 ·European Journal of Clinical Investigation ·Zvi Farfel, Haim Mayan, (unknown), Meir Mouallem, M Shaharabany, Rachel Pauzner, Eitan Kerem, Michael Wilschanski	18
7	Hypercalciuria in Familial Hyperkalemia and Hypertension Accompanies Hyperkalemia and Precedes Hypertension: Description of a Large Family with the Q565E WNK4 Mutation 2004 ·The Journal of Clinical Endocrinology & Metabolism ·Haim Mayan, Gabriel Munter, M Shaharabany, Meir Mouallem, Rachel Pauzner, Eliezer J. Holtzman, Zvi Farfel	72
8	Met-HGF/SF Signal Transduction Induces Mimp, a Novel Mitochondrial Carrier Homologue, Which Leads to Mitochondrial Depolarization 2002 ·Neoplasia ·(unknown), Raya Leibowitz‐Amit, M Shaharabany, Ilan Tsarfaty	24
9	In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors. 2001 ·PubMed ·M Shaharabany, Rinat Abramovitch, Tamar Kushnir, Galia Tsarfaty, (unknown), Judith Horev, (unknown), Y Itzchak, Ilan Tsarfaty	23
10	Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells 2000 ·Oncogene ·(unknown), M Shaharabany, Rom T. Altstock, Judith Horev, A. Abramovici, James H. Resau, George F. Vande Woude, Ilan Tsarfaty	47
11	Secreted Spitz triggers the DER signaling pathway and is a limiting component in embryonic ventral ectoderm determination. 1995 ·Genes & Development ·Ronen Schweitzer, M Shaharabany, Rony Seger, Ben‐Zion Shilo	287
12	The catalytic properties of the reverse transcriptase of the lentivirus equine infectious anemia virus 1994 ·European Journal of Biochemistry ·Tamar Rubinek, Shoshana Loya, M Shaharabany, Stephen H. Hughes, Patrick K. Clark, Amnon Hizi	11
13	Expression and Mutational Analysis of the Reverse Transcriptase of the Lentivirus Equine Infectious Anemia Virus 1993 ·Biochemical and Biophysical Research Communications ·M Shaharabany, Nancy R. Rice, Amnon Hizi	8
14	Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors 1993 ·Antimicrobial Agents and Chemotherapy ·Amnon Hizi, R. Tal, M Shaharabany, Michael J. Currens, Michael R. Boyd, Stephen H. Hughes, James B. McMahon	78
15	The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2. 1992 ·Journal of Biological Chemistry ·M Shaharabany, Amnon Hizi	35
16	The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2. 1992 ·Journal of Biological Chemistry ·Amnon Hizi, M Shaharabany, R. Tal, S H Hughes	25
17	Functional analysis of novel selective mutants of the reverse transcriptase of human immunodeficiency virus type 1. 1992 ·Journal of Biological Chemistry ·Amnon Hizi, M Shaharabany	12
18	The DNA-Dependent and RNA-Dependent DNA Polymerase Activities of the Reverse Transcriptases of Human Immunodeficiency Viruses Types 1 and 2 1991 ·AIDS Research and Human Retroviruses ·M Shaharabany, Amnon Hizi	14
19	Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. 1991 ·Journal of Biological Chemistry ·Amnon Hizi, R. Tal, M Shaharabany, Shoshana Loya	119
20	Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase 1990 ·Virology ·Amnon Hizi, Stephen H. Hughes, M Shaharabany	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact